Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Prevalence of OSA in COPD and the Clinical Impact of OSA Diagnosis and Treatment

NCT05042154 is registered in ClinicalTrials.gov with Atlantic Health System as lead sponsor.

NCT NCT05042154
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05042154 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Prevalence of OSA in COPD and the Clinical Impact of OSA Diagnosis and Treatment
Lead sponsor
Atlantic Health System
Phase
Not applicable
Overall status
Unknown status
Start date
October 31, 2021
Completion date
January 1, 2023
Enrollment
300 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

prevalence of osa in patients hospitalized with copd exacerbation